arrow
Back
J

Jörg Schrader

Philipps University Marburg

23H-index
127Paper Count
2.4KCitation Count
Published Papers 34
Publication Date
Crosstalk of TGF-β and somatostatin signaling in adenocarcinoma and neuroendocrine tumors of the pancreas: a brief review
err2025-03-11
err0
errOAAI
errUngefroren, Hendrik; Randeva, Harpal; Lehnert, Hendrik; Schrader, Joerg; Marquardt, Jens-Uwe; Konukiewitz, Bjoern; Hass, Ralf
errShare
errSave
The Novel SSTR3 Full Agonist ITF2984 Shows Antitumor Properties against Pancreatic Neuroendocrine Tumors
err2024-12-28
err0
PREAI
errBistika, Margarita; Marangelo, Alessandro; Ascione, Francesco; Valentini, Nicole; Fedeli, Francesco; Schrader, Jorg; Modena, Daniela; Steinkuehler, Christian; Pellegata, Natalia S.
errShare
errSave
Characterization of Epithelial-Mesenchymal and Neuroendocrine Differentiation States in Pancreatic and Small Cell Ovarian Tumor Cells and Their Modulation by TGF-β1 and BMP-7
errCELLS
IF5.2
err2024-12-05
err0
errOAAI
errUngefroren, Hendrik; von der Ohe, Juliane; Braun, Ruediger; Gaetje, Yola; Lapshyna, Olha; Schrader, Joerg; Lehnert, Hendrik; Marquardt, Jens-Uwe; Konukiewitz, Bjoern; Hass, Ralf
errShare
errSave
Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor
err2024-08-01
err0
PREAI
errChow, Zeta; Johnson, Jeremy; Chauhan, Aman; Jeong, Jong Cheol; Castle, Jennifer T.; Izumi, Tadahide; Weiss, Heidi; Townsend Jr, Courtney M.; Schrader, Joerg; Anthony, Lowell; Yang, Eddy S.; Evers, B. Mark; Rychahou, Piotr
errShare
errSave
Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues (vol 3, pg 581, 2022)
err2024-04-11
err0
errOAAI
errFeng, Zijie; He, Xin; Zhang, Xuyao; Wu, Yuan; Xing, Bowen; Knowles, Alison; Shan, Qiaonan; Miller, Samuel; Hojnacki, Taylor; Ma, Jian; Katona, Bryson W.; Gade, Terence P. F.; Siegel, Don L.; Schrader, Jorg; Metz, David C.; June, Carl H.; Hua, Xianxin
errShare
errSave
Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies
err2024-03-01
err0
errOAAI
errApril-Monn, Simon L.; Kirchner, Philipp; Detjen, Katharina; Braeutigam, Konstantin; Trippel, Mafalda A.; Grob, Tobias; Statzer, Cyril; Maire, Renaud S.; Kollar, Attila; Chouchane, Aziz; Kunze, Catarina A.; Horst, David; Sadowski, Martin C.; Schrader, Joerg; Marinoni, Ilaria; Wiedenmann, Bertram; Perren, Aurel
errShare
errSave
Does gamma-glutamyltransferase correlate with liver tumor burden in neuroendocrine tumors?
err2023-09-28
err3
errOAAI
errSchmidt, Benjamin Christopher; Leiderer, Miriam Theresa; Amin, Tania; Viol, Fabrice; Huber, Samuel; Henes, Frank Oliver; Schrader, Joerg
errShare
errSave
Cancer associated fibroblasts induce proliferation and therapeutic resistance to everolimus in neuroendocrine tumors through STAT3 activation
err2022-12-06
err7
PREAI
errAmin, Tania; Viol, Fabrice; Krause, Jenny; Fahl, Martina; Eggers, Corinna; Awwad, Fayez; Schmidt, Benjamin; Benten, Daniel; Ungefroren, Hendrik; Fraune, Christoph; Clauditz, Till S.; Sauter, Guido; Izbicki, Jakob R.; Lohse, Ansgar W.; Huber, Samuel; Schrader, Joerg
errShare
errSave
Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy
err2022-10-21
err6
errOAAI
errViol, Fabrice; Sipos, Bence; Fahl, Martina; Clauditz, Till S.; Amin, Tania; Kriegs, Malte; Nieser, Maike; Izbicki, Jakob R.; Huber, Samuel; Lohse, Ansgar W.; Schrader, Joerg
errShare
errSave
MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes (vol 27, pg 3997, 2020)
err2022-04-21
err0
errOAAI
errFraune, Christoph; Burandt, Eike; Simon, Ronald; Hube-Magg, Claudia; Makrypidi-Fraune, Georgia; Kluth, Martina; Buescheck, Franziska; Hoflmayer, Doris; Blessin, Niclas Ch.; Mandelkow, Tim; Li, Wenchao; Perez, Daniel; Izbicki, Jakob R.; Wilczak, Waldemar; Sauter, Guido; Schrader, Joerg; Neipp, Michael; Mofid, Hamid; Daniels, Thies; Isbert, Christoph; Clauditz, Till S.; Steurer, Stefan
errShare
errSave
Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
err2021-11-12
err3
errOAAI
errKrug, Sebastian; Kegel, Thomas; Gress, Thomas M.; Rinke, Anja; Apostolidis, Leonidas; Jann, Henning; Koenig, Alexander; Hoersch, Dieter; Schrader, Joerg; Ettrich, Thomas J.; Richter, Michael; Steighardt, Joerg; Michl, Patrick
errShare
errSave
Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare Disease
err2021-10-06
err6
errOAAI
errMatrood, Sami; Apostolidis, Leonidas; Schrader, Joerg; Krug, Sebastian; Lahner, Harald; Ramaswamy, Annette; Librizzi, Damiano; Kender, Zoltan; Kroecher, Anke; Kreutzfeldt, Simon; Gress, Thomas Matthias; Rinke, Anja
errShare
errSave
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms
err2021-10-01
err21
errOAAI
errYang, Kevin C.; Kalloger, Steve E.; Aird, John J.; Lee, Michael K. C.; Rushton, Christopher; Mungall, Karen L.; Mungall, Andrew J.; Gao, Dongxia; Chow, Christine; Xu, Jing; Karasinska, Joanna M.; Colborne, Shane; Jones, Steven J. M.; Schrader, Joerg; Morin, Ryan D.; Loree, Jonathan M.; Marra, Marco A.; Renouf, Daniel J.; Morin, Gregg B.; Schaeffer, David F.; Gorski, Sharon M.
errShare
errSave
Localization Defines Streptozotocin/5-FU Response in Primary Pancreatic Neuroendocrine Tumours
err2021-08-05
err3
PREAI
errReher, Dominik; Fehrenbach, Uli; Kayser, Antonin; Pape, Ulrich-Frank; Henes, Frank Oliver; Cremer, Birgit; Hoersch, Dieter; Izbicki, Jakob; Lohse, Ansgar Wilhelm; Rinke, Anja; Schrader, Joerg
errShare
errSave
Clinical Features and Prognosis of Patients with Carcinoid Syndrome and Carcinoid Heart Disease - a Retrospective Multicentric Study of 276 Patients
err2021-07-26
err13
PREAI
errFijalkowski, R.; Reher, D.; Rinke, A.; Gress, T. M.; Schrader, J.; Baum, R. P.; Kaemmerer, D.; Hoersch, D.
errShare
errSave
Finding the Appropriate Therapeutic Strategy in Patients with Neuroendocrine Tumors of the Pancreas: Guideline Recommendations Meet the Clinical Reality
err2021-07-07
err10
errOAAI
errKrug, Sebastian; Damm, Marko; Garbe, Jakob; Koenig, Senta; Schmitz, Rosa Lynn; Michl, Patrick; Schrader, Jorg; Rinke, Anja
errShare
errSave
Targeting HDACs in Pancreatic Neuroendocrine Tumor Models
errCELLS
IF5.2
err2021-06-06
err17
errOAAI
errSchmitz, Rosa Lynn; Weissbach, Julia; Kleilein, Jan; Bell, Jessica; Huettelmaier, Stefan; Viol, Fabrice; Clauditz, Till; Grabowski, Patricia; Laumen, Helmut; Rosendahl, Jonas; Michl, Patrick; Schrader, Joerg; Krug, Sebastian
errShare
errSave
PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors
errCELLS
IF5.2
err2021-05-20
err15
errOAAI
errChow, Zeta; Johnson, Jeremy; Chauhan, Aman; Izumi, Tadahide; Cavnar, Michael; Weiss, Heidi; Townsend, Courtney M., Jr.; Anthony, Lowell; Wasilchenko, Carrigan; Melton, Matthew L.; Schrader, Joerg; Evers, B. Mark; Rychahou, Piotr
errShare
errSave
Leptomeningeal Carcinomatosis: A Clinical Dilemma in Neuroendocrine Neoplasms
err2021-03-28
err0
errOAAI
errApostolidis, Leonidas; Schrader, Jorg; Jann, Henning; Rinke, Anja; Krug, Sebastian
errShare
errSave
Professional Assessment of the Impact of COVID-19 on Handling NET Patients
err2020-11-11
err9
errOAAI
errKrug, Sebastian; Garbe, Jakob; Koenig, Senta; Ungewiss, Hanna; Michl, Patrick; Rinke, Anja; Schrader, Joerg
errShare
errSave